Round Type
Series C
ClevelandBiotechnologyHealthcareDescription
Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company that leverages a novel hepatocyte cell targeting platform to develop innovative therapies for diabetes, obesity, and other metabolic disorders, has announced the first closing of its Series C financing today. This funding round, led by current investors, also includes participation from Eli Lilly and Company.
Quick answer
Diasome Pharmaceuticals raised an undisclosed amount in a Series C round, dated December 7, 2023. Diasome Pharmaceuticals is based in Cleveland, Ohio, United States.
- How much did Diasome Pharmaceuticals raise?
- Diasome Pharmaceuticals raised an undisclosed amount in a Series C round on December 7, 2023.
- What does Diasome Pharmaceuticals do?
- Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell drug targeting to restore hepatocyte metabolism and treat metabolic diseases.
- Where is Diasome Pharmaceuticals based and how big is it?
- Diasome Pharmaceuticals is based in Cleveland, Ohio, United States.
- Who are the decision-makers at Diasome Pharmaceuticals?
- Fundz holds 1 contact at Diasome Pharmaceuticals, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Diasome Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Singletto raised $65K (Pre-Seed) on January 17, 2024.
- Avant Sciences raised $175K on January 12, 2024.
- Streamex Corp. raised $1.5M (Seed) on January 12, 2024.
- ViaLase raised $45M (Seed) on January 5, 2024.
- Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
- Reimagine Care raised an undisclosed amount (Corporate Round) on January 4, 2024.
Who to call at Diasome Pharmaceuticals, and when
A new round usually means Diasome Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Diasome Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Diasome Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Diasome Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Diasome Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Diasome Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.